Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 18, 2009
Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impactLucia Di Micco, Serena Torraca, Andrea Pota, et al.Diabetes Technology & Therapeutics|July 2, 2025
Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People with Type 1 Diabetes in FranceHelene Hanaire, Asli Zeynep Ozdemir Saltik, Richard F Pollock, et al.Journal of Diabetes Science and Technology|March 23, 2023
Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose MonitoringTim van den Heuvel, Ralf Kolassa, Winfried Keuthage, et al.Diabetes Technology & Therapeutics|May 16, 2020
Predicting Factors Associated with Hypoglycemia Reduction with Automated Predictive Insulin Suspension in Patients at High Risk of Severe Hypoglycemia: An Analysis from the SMILE Randomized TrialAklilu Habteab, Javier Castañeda, Harold de Valk, et al.Autoimmunity|January 8, 2008
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndromePiercarlo Sarzi-Puttini, Fabiola Atzeni, Manuela Di Franco, et al.Rheumatology (Oxford, England)|May 26, 2009
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patientsMaurizio Turiel, Fabiola Atzeni, Livio Tomasoni, et al.The Lancet. Diabetes & Endocrinology|September 4, 2022
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled studyPratik Choudhary, Ralf Kolassa, Winfried Keuthage, et al.The Lancet. Diabetes & Endocrinology|May 4, 2019
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trialEmanuele Bosi, Pratik Choudhary, Harold W de Valk, et al.Dermatologic Therapy|February 9, 2010
Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care systemSimona de Portu, Micol Del Giglio, Gianfranco Altomare, et al.Diabetes, Obesity & Metabolism|August 8, 2023
Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetesShannon N Edd, Javier Castañeda, Pratik Choudhary, et al.Pageof 5